<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03534960</url>
  </required_header>
  <id_info>
    <org_study_id>XH-17-007</org_study_id>
    <nct_id>NCT03534960</nct_id>
  </id_info>
  <brief_title>High Flow Nasal Oxygen Therapy in Pediatric Hypercapnic Respiratory Failure During Perioperative Stage</brief_title>
  <official_title>High Flow Nasal Oxygen Therapy in Pediatric Hypercapnic Respiratory Failure During Perioperative Stage</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Xinhua Hospital, Shanghai Jiao Tong University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Xinhua Hospital, Shanghai Jiao Tong University School of Medicine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Humidified high flow nasal oxygen therapy decreases dilution of the inhaled oxygen and, by
      matching patient's peak flow, allows accurate delivery of the set FiO2 throughout the whole
      inspiratory phase.The purpose of this study is to determine the impact of hign-flow nasal
      therapy on pediatric hypercapnic respiratory failure by comparing with nasal continuous
      positive airway pressure.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Humidified high flow nasal oxygen therapy decreases dilution of the inhaled oxygen and, by
      matching patient's peak flow, allows accurate delivery of the set FiO2 throughout the whole
      inspiratory phase.The purpose of this study is to determine the impact of hign-flow nasal
      therapy on pediatric hypercapnic respiratory failure by comparing with nasal continuous
      positive airway pressure
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 13, 2018</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">November 12, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the number of patients in each group who require endotracheal intubation w</measure>
    <time_frame>24 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>mechanical ventilation-free to day 28</measure>
    <time_frame>28 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Respiratory Insufficiency</condition>
  <arm_group>
    <arm_group_label>High Flow Nasal Oxygen Therapy</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patients are randomized to the high flow nasal oxygen therapy group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Nasal CPAP</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patients are randomized to the nasal continuous positive airway pressure treatment group</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>High Flow Nasal Oxygen Therapy</intervention_name>
    <description>Nasal cannula flows of 3 to 8 lpm via systems approved to provide increased humidification and warmth to inspired gas</description>
    <arm_group_label>High Flow Nasal Oxygen Therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Nasal CPAP</intervention_name>
    <description>Standard nasal CPAP via &quot;bubble&quot; or ventilator support at levels of 4-8 cm H2O</description>
    <arm_group_label>Nasal CPAP</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age ranges from 1 to 18 years

          2. Hypercapnic respiratory failure:

             PaO2&lt;60mmHg and PaCO2 &gt;50 mmHg

          3. Candidate for non-invasive respiratory support as a result of:

               1. an intention to manage the patient with non-invasive (no endotracheal tube)
                  respiratory support

               2. an intention to extubate the patient being managed with intubated respiratory
                  support to non-invasive support

        Exclusion Criteria:

          1. Participation in a concurrent study that prohibits the use of HHFNC

          2. Active air leak syndrome

          3. Patients with abnormalities of the upper and lower airways; such as Pierre- Robin,
             Treacher-Collins, Goldenhar, choanal atresia or stenosis,

          4. Patients with significant abdominal or respiratory malformations including
             tracheo-esophageal fistula, intestinal atresia, omphalocele, gastroschisis, and
             congenital diaphragmatic hernia

          5. PaCO2&lt;50mmHg
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>bin he</last_name>
    <phone>021-25077828</phone>
    <email>hebinicu@139.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>xingyu tong</last_name>
    <email>2433928723@qq.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Ethics Committee of Xinhua Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200092</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guangyu Chen, PhD</last_name>
      <phone>+86-02125076143</phone>
      <email>xinhuacru@163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 23, 2017</study_first_submitted>
  <study_first_submitted_qc>May 13, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 23, 2018</study_first_posted>
  <last_update_submitted>May 24, 2018</last_update_submitted>
  <last_update_submitted_qc>May 24, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 28, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Xinhua Hospital, Shanghai Jiao Tong University School of Medicine</investigator_affiliation>
    <investigator_full_name>Bin He</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Insufficiency</mesh_term>
    <mesh_term>Pulmonary Valve Insufficiency</mesh_term>
    <mesh_term>Hypercapnia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

